Your browser version may not work well with NCBI's Web applications. More information here...
1: Lancet. 2004 Jan 31;363(9406):381-91.Click here to read Links
Comment in:
Lancet. 2004 Apr 24;363(9418):1398-9; author reply 1399.
Lancet. 2004 Apr 24;363(9418):1398; author reply 1399.

Migraine.

Silberstein SD.

Jefferson Headache Centre, Thomas Jefferson University Hospital, Philadelphia, PA, USA. Stephen.Silberstein@jefferson.edu

Migraine is a very common neurobiological headache disorder that is caused by increased excitability of the CNS. It ranks among the world's most disabling medical illnesses. Diagnosis is based on the headache's characteristics and associated symptoms. The economic and societal effect of migraine is substantial: it affects patients' quality of life and impairs work, social activities, and family life. There are many acute and preventive migraine treatments. Acute treatment is either specific (triptans and ergots) or non-specific (analgesics). Disabling migraine should be treated with triptans. Increased headache frequency is an indication for preventive treatment. Preventive treatment decreases migraine frequency and improves quality of life. More treatments are being developed, which provides hope to the many patients whose migraines remain uncontrolled.

PMID: 15070571 [PubMed - indexed for MEDLINE]

Recent Activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on